Home / Tag Archives: Prediabetes (page 2)

Tag Archives: Prediabetes

Are Wearables Redefining Prediabetes — or Over-Medicalizing It?

Person using wearable glucose monitoring technology and smartphone app to track metabolic health and prediabetes risk

Prediabetes has traditionally been diagnosed during annual physical exams through fasting glucose tests or A1C measurements. However, new diabetes prevention tools and wearable technologies are rapidly changing that model. Today, wearable devices, continuous glucose monitors (CGMs), and predictive metabolic tracking tools are giving people real-time insight into their glucose patterns …

Read More »

The Diabetes Diagnosis Gap: Are We Missing Patients Who Don’t Fit Classic Risk Profiles?

Doctor reviewing a patient for possible diabetes misdiagnosis using diagnostic tools in a clinical setting

Diabetes screening has improved over the last two decades, yet many patients still fall through the cracks. While clinicians often rely on traditional risk models that focus on obesity, age, family history, and sedentary lifestyle, not every patient with diabetes fits that familiar picture. As a result, many diabetes cases …

Read More »

GLP-1s in Young Adults: Rethinking Metabolic Risk and Early Intervention

Young adults consulting with a physician about GLP-1 therapy for obesity and early metabolic risk management

For years, GLP-1 receptor agonists have been associated with older adults who already have type 2 diabetes or established cardiovascular disease. However, metabolic dysfunction does not suddenly appear at age 60. In fact, obesity, insulin resistance, and prediabetes often begin decades earlier. That is why conversations around GLP-1 therapy in …

Read More »

Reframing Prediabetes: Can Structured Lifestyle Programs Delay or Avoid Medication Use?

A flat lay of diabetes prevention tools including a glucose meter, apple, dumbbells, measuring tape, notebook, and clipboard labeled "Diabetes Prevention Program"

Prediabetes affects a striking proportion of adults worldwide, creating a crucial window for intervention before type 2 diabetes develops. While medications like metformin are frequently considered for high-risk individuals, evidence from large clinical trials shows that lifestyle-based strategies — especially the National Diabetes Prevention Program — can dramatically reduce the …

Read More »